Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Rev Med Interne ; 38(2): 81-89, 2017 Feb.
Article in French | MEDLINE | ID: mdl-27659745

ABSTRACT

INTRODUCTION: Nocardiosis are uncommon. The diagnosis may be difficult, with significant morbidity and mortality, often occurring on frail patients. Few data are available in France. METHODS: A retrospective single center study was conducted from 2002 to 2014 and included all patients with at least one positive microbiological sample for Nocardia with a follow-up in our hospital. RESULTS: Nineteen patients, including 15 men, were included with a mean age of 58 years (25-85). Seventeen had a risk factor (lung diseases [13], corticosteroids [12], solid neoplasia [2], HIV infection [2], diabetes mellitus [3], kidney transplant [2], lymphopenia [1]). Infections' locations were: pulmonary (12), brain (3), skin (2), lymph node (1) and corneal (1). The slow growth leads to a median of 35 days for a positive result (3-95). Nine species were identified. Fifteen patients (79%) received one or more lines of antibiotics including: cotrimoxazole (9), amoxicillin (7) cefotaxime/ceftriaxone (7) imipenem (3), or amikacin (3). The average duration of antibiotic therapy was 207 days. Four patients did not receive antibiotics due to a late result or a bacterial co-infection masking nocardiosis. Five patients died (26%) including 2 with cerebral nocardiosis. Six patients were cured, 4 suffered a relapse, 4 had an unknown evolution, and 1 was still treated. CONCLUSION: Our study shows that nocardiosis is a disease difficult to treat. A better understanding of this type of infection is necessary.


Subject(s)
Nocardia Infections , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Coinfection , Female , France/epidemiology , HIV Infections/complications , HIV Infections/drug therapy , HIV Infections/epidemiology , Humans , Immunocompromised Host , Lung Diseases/complications , Lung Diseases/drug therapy , Lung Diseases/epidemiology , Male , Middle Aged , Nocardia/isolation & purification , Nocardia Infections/diagnosis , Nocardia Infections/drug therapy , Nocardia Infections/epidemiology , Nocardia Infections/microbiology , Retrospective Studies , Risk Factors
3.
Rev Mal Respir ; 32(5): 530-4, 2015 May.
Article in French | MEDLINE | ID: mdl-26072009

ABSTRACT

INTRODUCTION: The Doege-Potter syndrome is a rare paraneoplastic syndrome, first described by Doege and Potter in 1930, that usually involves solid fibrous pleural tumours. Hypoglycaemia is a rare complication of these tumours, due to secretion of insulin-like growth factors, and it can be the presenting symptom. The incidence of malignancy is low, about 12-15 %. CASE REPORT: An 81-year-old Caucasian man, operated on 20 years previously for a benign pleural fibroma, presented with several episodes of loss of consciousness due to profound hypoglycaemia and a history of increasing dyspnea. The chest X-ray revealed an intrathoracic mass. Following excision histological examination confirmed recurrence with malignant transformation to a high-grade sarcoma. CONCLUSION: The Doege-Potter syndrome is a rare condition but it should be suspected in episodes of hypoglycaemia associated with a history of dyspnea. These patients should be followed up postoperatively because of the risk of tumour recurrence.


Subject(s)
Coma/etiology , Hypoglycemia/etiology , Insulin-Like Growth Factor II/metabolism , Neoplasm Recurrence, Local/metabolism , Paraneoplastic Syndromes/etiology , Pleural Neoplasms/metabolism , Sarcoma/metabolism , Aged, 80 and over , Biopsy , Disease Progression , Dyspnea/etiology , Fatal Outcome , Humans , Male , Pleural Neoplasms/pathology , Pleural Neoplasms/radiotherapy , Pleural Neoplasms/surgery , Sarcoma/pathology , Sarcoma/radiotherapy , Solitary Fibrous Tumor, Pleural/pathology , Solitary Fibrous Tumor, Pleural/surgery , Thoracic Surgery, Video-Assisted
SELECTION OF CITATIONS
SEARCH DETAIL
...